HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Murat Emre Selected Research

Rivastigmine (Exelon)

1/2014Long-term safety of rivastigmine in parkinson disease dementia: an open-label, randomized study.
4/2011Cognitive correlates of visual hallucinations in dementia associated with Parkinson's disease.
8/2010Drug profile: transdermal rivastigmine patch in the treatment of Alzheimer disease.
1/2010Effects of rivastigmine in Alzheimer's disease patients with and without hallucinations.
1/2008Effects of rivastigmine on tremor and other motor symptoms in patients with Parkinson's disease dementia: a retrospective analysis of a double-blind trial and an open-label extension.
10/2007Subthreshold depression in patients with Parkinson's disease and dementia--clinical and demographic correlates.
7/2007Rivastigmine in dementia associated with Parkinson's disease and Alzheimer's disease: similarities and differences.
11/2006Effects of rivastigmine in patients with and without visual hallucinations in dementia associated with Parkinson's disease.
4/2006Long-term benefits of rivastigmine in dementia associated with Parkinson's disease: an active treatment extension study.
12/2004Rivastigmine for dementia associated with Parkinson's disease.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Murat Emre Research Topics

Disease

23Dementia (Dementias)
10/2020 - 04/2003
19Alzheimer Disease (Alzheimer's Disease)
01/2016 - 01/2003
18Parkinson Disease (Parkinson's Disease)
01/2021 - 09/2003
6Parkinsonian Disorders (Parkinsonism)
01/2016 - 01/2007
5Hallucinations (Hallucination)
04/2019 - 11/2006
3Dyskinesias (Dyskinesia)
07/2013 - 05/2010
3Cognitive Dysfunction
08/2011 - 02/2009
2Frontotemporal Dementia (Semantic Dementia)
01/2019 - 01/2016
2Pallidopyramidal syndrome
07/2015 - 09/2010
2Psychotic Disorders (Schizoaffective Disorder)
04/2014 - 04/2005
2Atrophy
12/2013 - 03/2007
2Tremor (Tremors)
01/2008 - 12/2004
1Inborn Genetic Diseases (Disease, Hereditary)
09/2021
1Hepatolenticular Degeneration (Wilson's Disease)
09/2021
1Neurologic Manifestations (Neurological Manifestations)
09/2021
1Autonomic Nervous System Diseases (Dysautonomia)
10/2020
1Neurobehavioral Manifestations
04/2019
1Cerebrotendinous Xanthomatosis
01/2019
1Spontaneous Abortion (Miscarriage)
08/2018
1Fetal Distress
08/2018
1Down Syndrome (Down's Syndrome)
08/2018
1Neurodegeneration with brain iron accumulation (NBIA)
01/2017
1Phenylketonurias (Phenylketonuria)
01/2016
1Amyotrophic Lateral Sclerosis (Lou Gehrig's Disease)
01/2016
1Body Weight (Weight, Body)
07/2013
1Disease Progression
06/2012
1Pain (Aches)
01/2011
1Stroke (Strokes)
10/2010
1Pantothenate Kinase-Associated Neurodegeneration (Hallervorden-Spatz Disease)
09/2010
1Kufor-Rakeb syndrome
09/2010
1Disorders of Excessive Somnolence (Hypersomnia)
04/2009
1Hyperhomocysteinemia
02/2009
1Hypokinesia (Bradykinesia)
01/2008
1Neurodegenerative Diseases (Neurodegenerative Disease)
07/2007
1Status Epilepticus (Complex Partial Status Epilepticus)
03/2007
1Amyloid Plaque
02/2006
1Nausea
12/2004
1Vomiting
12/2004
1Dystonia (Limb Dystonia)
03/2004

Drug/Important Bio-Agent (IBA)

10Levodopa (L Dopa)FDA LinkGeneric
10/2020 - 09/2003
10Rivastigmine (Exelon)FDA LinkGeneric
01/2014 - 12/2004
7Cholinergic Agents (Cholinergics)IBA
09/2012 - 08/2004
5Cholinesterase Inhibitors (Anticholinesterases)IBA
08/2010 - 01/2003
4Antipsychotic Agents (Antipsychotics)IBA
04/2019 - 03/2004
4entacapone (Comtan)FDA Link
07/2013 - 09/2003
3Memantine (Namenda)FDA Link
10/2010 - 06/2008
3ButyrylcholinesteraseIBA
02/2009 - 04/2006
2alpha-SynucleinIBA
01/2021 - 02/2006
2rasagiline (Azilect)FDA Link
08/2018 - 08/2011
2Proteins (Proteins, Gene)FDA Link
01/2017 - 08/2012
2Apolipoproteins E (ApoE)IBA
01/2016 - 02/2009
2Carbidopa (Lodosyn)FDA LinkGeneric
07/2013 - 02/2012
2Calcitriol Receptors (Calcitriol Receptor)IBA
11/2012 - 07/2007
2LigandsIBA
11/2012 - 07/2007
2methyl 4-azidophenylacetimidate (APAI)IBA
11/2012 - 07/2007
2Donepezil (Aricept)FDA LinkGeneric
09/2012 - 01/2004
2perampanelIBA
01/2012 - 05/2010
2Dopamine Agonists (Dopamine Agonist)IBA
01/2011 - 04/2009
2Pharmaceutical PreparationsIBA
08/2010 - 12/2004
2AcetylcholinesteraseIBA
11/2006 - 04/2006
2Clozapine (Clozaril)FDA LinkGeneric
04/2005 - 03/2004
1CopperIBA
09/2021
1Messenger RNA (mRNA)IBA
01/2019
1ProgranulinsIBA
01/2019
1LipidsIBA
01/2019
1Indicators and Reagents (Reagents)IBA
01/2019
1BenserazideIBA
08/2018
1Pramipexole (Mirapex)FDA LinkGeneric
08/2018
1Piribedil (Trivastal)IBA
08/2018
1GranulinsIBA
01/2016
1Tyrosine (L-Tyrosine)FDA Link
01/2016
1Microtubule-Associated Proteins (Microtubule-Associated Protein 2)IBA
01/2016
1ClusterinIBA
01/2016
1Phenylalanine (L-Phenylalanine)FDA Link
01/2016
1Phenylalanine Hydroxylase (Phenylalanine 4 Monooxygenase)IBA
01/2016
1F-Box ProteinsIBA
07/2015
1Olanzapine (Zyprexa)FDA Link
04/2014
1Risperidone (Risperdal Consta)FDA LinkGeneric
04/2014
1Biomarkers (Surrogate Marker)IBA
10/2013
1StalevoIBA
07/2013
1DNA (Deoxyribonucleic Acid)IBA
11/2012
1Amyloid (Amyloid Fibrils)IBA
08/2012
1Excitatory Amino Acid AntagonistsIBA
01/2012
1propionic acid (potassium propionate)IBA
01/2012
1Monoamine Oxidase (MAO)IBA
08/2011
1N-Methyl-D-Aspartate Receptors (NMDA Receptors)IBA
10/2010
1IronIBA
09/2010
1AMPA Receptors (AMPA Receptor)IBA
05/2010
1ApolipoproteinsIBA
02/2009
1Dihydroxyphenylalanine (Dopa)IBA
01/2009
1Interleukin-1alpha (Interleukin 1 alpha)IBA
01/2009
1Presenilin-1IBA
12/2008
1Cholinergic Antagonists (Anticholinergics)IBA
01/2008
1Vitamin DFDA LinkGeneric
07/2007
1Cholecalciferol (Vitamin D3)FDA Link
07/2007
1Penicillins (Penicillin)FDA Link
03/2007
1Choline O-Acetyltransferase (Choline Acetyltransferase)IBA
02/2006

Therapy/Procedure

8Activities of Daily Living (ADL)
01/2014 - 09/2003
3Therapeutics
07/2013 - 03/2004
1Polypharmacy
04/2005